Virtual Rheumatology


Live Webcast: Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis

Wednesday, November 4, 2020  |  6:30 PM – 8:00 PM ET Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease with a significant impact on quality of life and functional ability. Despite the data showing the overall impact of PsA, delays in diagnosis are common, which can lead to long-term joint damage and functional disability. […]

Read More